Drug Companies Seek Trademarks At Early Stage, Survey Finds

Law360, New York (February 19, 2004, 12:00 AM EST) -- Drug companies are developing trademarks for new products at an early stage in an effort to entrench a brand in the minds of physicians, a new survey has found.

The overwhelming majority of the companies surveyed develops the generic and trademark names--92% and 84% respectively--by or during Phase II of clinical trials, according to a new benchmark study by consulting firm Best Practices, LLC.

As many as 40% of companies use the trademark before using the generic name, reflecting a growing trend to entrench the trademark...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.